1. PBAC (Pharmaceutical Benefits Advisory Committee). Guidelines for preparing submissions to the pharmaceutical benefits advisory committee. Australia: Australian Government Department of Health; 2013.
2. CADTH (Canadian Agency for Drugs and Technologies in Health). Guidelines for the economic evaluation of health technologies. Canada: CADTH; 2006.
3. HAS (Haute Autorité de Santé). Choices in methods for economic evaluation. France: HAS; 2012.
4. CVZ (College voor zorgverzekeringen). Guidelines for pharmacoeconomic research: evaluation and actualisation. Diemen: CVZ; 2006.
5. CatSalut. Guia I Recomanacions Per A La Realització I Presentació D’avaluacions Econòmiques I Anàlisis D’impacte Pressupostari De Medicaments En L’àmbit Del Catsalut. Catalonia: CatSalut; 2014.